CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

CTMXCytomX Therapeutics, Inc.

NASDAQ · Pharmaceutical Preparations
Last close $2.72 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$592.69M
RECENT INSIDER TRADES
  • 2026-06-17 · Ogden Christopher (Chief Financial Officer) · SELL
  • 2026-03-19 · Chu Yu-Waye (Chief Medical Officer) · SELL
  • 2026-03-19 · Ogden Christopher (Chief Financial Officer) · SELL
  • 2026-03-19 · McCarthy Sean A. (CEO) · SELL
  • 2026-03-19 · BELVIN MARCIA (SVP, Chief Scientific Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders184
Shares held223,122,137
Value$837.67M
Percent of shares outstanding102.40%
As of quarter end2026-06-30
RECENT NEWS
  • CytomX Therapeutics presents at Morgan Stanley healthcare conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS